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Deoxyribonuclease I finds extensive application in the fields of both nucleic acid and cell motility research. 
This paper describes the use of the cationic exchange column MonoQ, marketed by Pharmacia as part of 
their Fast Protein Liquid Chromatography system, for further purification of the enzyme from 
commercially available material. Up to 7 mg DNase I of high purity can be obtained in a single separation 
step taking about 20 min to perform. The quality of the product is documented using 3 independent assay 
criteria. 
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1. INTRODUCTION 
Since the demonstration in 1974 [l] that actin is 
a specific inhibitor of deoxyribonuclease I, a 
secretory endonuclease from pancreas, the enzyme 
has found extensive application in the field of cell 
motility research. Even before identification of the 
DNase inhibitor as actin, immobilised DNase was 
introduced as an affinity purification medium for 
the inhibitor [2], and this technique has been of 
particular value in isolating and studying proteins 
which interact with actin (see [3-51). Antibodies 
against DNase have been used together with DNase 
itself in a sandwich immunofluorescence method 
for localisation of actin in cells (see [6]). Inhibition 
of the enzyme by actin has also been exploited in 
a rapid assay which discriminates between 
monomeric and filamentous actin in cell extracts 
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ly. Chromatographic procedures for further 
purification of DNase I have been reported [8,9], 
but experience in our laboratory has not found 
these methods satisfactory for routine purification 
of the enzyme from the ‘DN-100’ grade material 
supplied by Sigma, which we have used as our 
major source of DNase. Acceptable purification 
can sometimes be obtained by a single-step gel 
filtration on Sephadex GlOO [lo], but inactive 
components in the DN-100 are not always resolved 
from the enzyme on this medium. Good separation 
of the enzyme from impurities can be obtained by 
gel filtration on Sephadex G75 Superfine (L. 
Carlsson and S. Eriksson, unpublished), but ap- 
plication of this method on a useful scale requires 
a large column, and the low flow rates make pre- 
paration a long process. 
Bovine deoxyribonuclease I is commercially 
available from many suppliers, but pure material is 
discouragingly expensive for purposes requiring 
stoichiometric rather than enzymatic amounts. Im- 
purities in the cheaper grades often include pro- 
teases and other nucleases, particularly unwelcome 
in the fields of actin and DNA research, respective- 
I report here that DNase I can be purified rapid- 
ly on the MonoQ cationic exchange column 
marketed by Pharmacia as a component in their 
Fast Protein Liquid Chromatography (FPLC) 
system. Starting with Sigma DN-100 containing 
not more than 35% DNase, high recovery of activi- 
ty in electrophoretically homogeneous material is 
achieved in a single separation step taking about 
15-20 min to perform. The commercially 
available MonoQ column has sufficient capacity to 
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prepare at least 7 mg of purified DNase in one 
step. Re-equilibration of the column in prepara- 
tion for a repeated run takes no more than 5 min, 
SO that very large amounts of DNase can be exten- 
sively purified in one working day. 
2. EXPERIMENTAL 
Deoxyribonuclease I, grades DN-100 and DN- 
EP, was obtained from Sigma (St. Louis, MO). 
Purification of DNase I by gel filtration on 
Sephadex G75 Superfine was performed in 10 mM 
Tris-HCl, pH 7.6, 150 mM NaCl, 0.5 mM CaClz: 
the gel-filtered sample used here had been stored 
for about 3 years at -20°C in this buffer. 
Chromatography on a ready-packed MonoQ ca- 
tion exchange column (Pharmacia HR5/5) used 
the complete Pharmacia FPLC system with pro- 
grammable FRAC-100 fraction collector. The only 
components essential to the separation are the col- 
umn itself and a pump capable of delivering suffi- 
cient pressure (about 2.5 MPa is required for a 
flow rate of 1.5 ml/min). A gradient programmer 
facilitates reproducible separations, and a monitor 
and ‘intelligent’ fraction collector permit auto- 
mated handling of large batches. 
Amounts of protein were determined from ab- 
sorbance at 280 nm, assuming an extinction of 1.2 
for a solution of 1 mg/ml (the correct value for 
DNase I [lo]). 
Nuclease activity was measured in terms of the 
rate of increase in A260 in a sample of calf thymus 
DNA type I (Sigma) as in [7], and expressed as 
change in absorbance/min. No attempt was made 
to correlate measured activities with the supplier’s 
specifications in Kunitz units. 
The conditions for the assay of inhibition of 
DNase by actin have been described [7]. The assay, 
initially designed to measure actin, was used to 
estimate the amount of DNase I in a sample as 
follows. The percentage inhibition of the DNase 
sample by a known amount of pure calf spleen ac- 
tin (obtained as in [ll]) was first measured, and 
used to calculate the amount of actin needed for 
complete inhibition of the DNase on a linear basis. 
This figure was then converted to amount of 
DNase I assuming equimolar binding of actin to 
DNase[12,13]andM,of31000[10]and42000[14] 
for DNase and actin, respectively. 
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Electrophoresis on SDS-15070 polyacrylamide 
gels was performed as in [ 151. Gels were stained 
with Coomassie blue R250 and scanned on an LKB 
Ultroscan laser densitometer. 
3. RESULTS AND DISCUSSION 
The starting material for the experiments 
described below was a batch of DNase I from 
Sigma, grade DN-100, of relatively high purity ac- 
cording to the product description (1505 Kunitz 
units/mg protein, compared with about 2400 
units/mg for Sigma’s electrophoretically pure DN- 
EP). Fig.1 shows chromatography of a sample of 
this DN-100 on MonoQ cationic exchanger, ap- 
plied in 10 mM Tris-HCl (pH 7.6), 0.5 mM 
CaC12, and eluted with a gradient of NaCl as 
shown. Several peaks of absorbance at 280 nm are 
apparent, with the bulk of the material divided bet- 
ween the flowthrough and a complex of two major 
and several minor peaks eluting between about 
150 mM and 250 mM NaCl. The bulk of the 
DNase activity was confined to the first major 
peak eluted with salt, although minor peaks of 
nuclease were also present in the flowthrough and 
in the second of the major eluted peaks. The 
recoveries of protein and nuclease activity are sum- 
marised in table 1. 
Electrophoretic analysis (fig. lb) revealed that 
the starting material contained several protein 
components. On the basis of molecular mass 
alone, the largest major band at about 31 kDa 
(marked with an arrow in fig.lb) is expected to 
represent DNase I. This band is essentially the sole 
constituent of the first major eluted peak, where 
the bulk of the nuclease activity was recovered, 
confirming the identification of the 31 kDa band 
as DNase I. Trace amounts of the 31 kDa compo- 
nent are also eluted in the flowthrough and the se- 
cond eluted peak. 
The chromatogram in fig.1 was loaded with 
about 4 mg DN-100 for analytical purposes. In 5 
successive applications of 7 mg each with no in- 
tervening elution, the amount of unadsorbed 
material remained unchanged, indicating that the 
column capacity was sufficient for at least 35 mg 
DN-100. Subsequent elution of this amount gave 
resolution comparable with that in fig.1, and 
yielded 7 mg protein in the active peak. 
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Fig. 1. Chromatography of DNase I on MonoQ ion 
exchanger. A sample containing 4.1 mg DNase I (Sigma 
DN-100) in 1 ml 10 mM Tris-HCI (pH 7.6), 0.5 mM 
CaClz was applied to a prepacked column of MonoQ 
(Pharmacia HRS/S) equilibrated with the same buffer, 
and was eluted with a linear gradient of NaCl from 
O-O.75 M at a flow rate of I .5 ml/min. (A) Absorbance 
at 280 nm (-) was monitored continuously, and 
fractions of 0.75 ml were collected. The salt gradient 
(---) was checked by condu~ivity measurements of 
selected fractions (marked x). The vertical arrow (‘(I) 
marks the major peak of nuclease activity. (B) Aliquots 
of the starting material and of each fraction were 
precipitated with cold acetone (final concentration 
70%), and analysed by electrophoresis on SDS-15% 
polyacrylamide gels. The sample marked ‘S’ is the 
material applied to the column: the remaining samples 
are identified by their fraction numbers. The band 
corresponding to DNase I (31 kDa) is marked with an 
arrow. 
Table 1 
Purification of DNase I on MonoQ ion exchanger 
% Protein % Nuclease Specific 
activity activitya 
Start 100 100 39.5 
Peak recoveryb 24 65 110 
Total recovery’ 96 85 
a Specific activity is expressed as nuclease activity/unit 
absorbance at 280 nm (see section 2) 
b Peak recovery summed over fractions 19-21 
’ Total recovery summed over the whole chromatogram 
The figures are calculated for the chromatogram in fig. 1 
Comparison of the product obtained from 
chromatography on MonoQ with DNase from 
other sources is shown in fig.2 and table 2. The 
other samples shown are Sigma DN-100 (the start- 
ing material for MonoQ chromatography), two 
separate batches of Sigma DN-EP (‘elec- 
1 2 3 45 
Fig.2. Comparison of different samples of DNase I by 
electrophoresis on SDS-IS% polyacrylamide gels. The 
samples are: (I) Sigma DN-100; (2) and (3) different 
batches of ‘electrophoretically pure’ DNase (DN-EP, 
Sigma); (4) DNase purified from DN-100 by 
chromatography on Sephadex G75 Superfine; (5) DNase 
purified from DN-100 by chromatography on MonoQ. 
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t~ophoretically pure’), and a preparation obtained 
by gel filtration of DN-100 on Sephadex G75 
Superfine. By SDS gel electrophoresis (fig.2), all 
the samples except DN-100 contain one dominant 
band in the position of DNase; however, the 
amount of minor contaminating bands is least in 
the product from MonoQ. 
This is expressed quantitatively in table 2, which 
summarises the purity of the 5 preparations by 3 
independent criteria. The first column gives the 
purity of the 3 1 kDa polypeptide measured by den- 
sitometry of the gel in fig.2. The second column 
shows the purity of each preparation estimated 
from the amount of actin required to inhibit the 
nuclease activity completely (see section 2). This 
measurement would overestimate the amount of 
DNase I if the sample contained components 
which interfered in any way with the actin-DNase 
interaction, and in particular if inactive DNase 
which retained its a~tin-binding activity were pre- 
sent. This latter source of error would not be 
revealed by a comparison of columns 1 and 2 as 
long as the inactivation did not involve a signifi- 
cant change in mobility on SDS gels. 
The figures in the third column of table 2 are the 
specific nuclease activity, expressed in terms of the 
rate of DNA hydrolysis per unit of material ab- 
sorbing at 280 nm (see section 2). These figures 
Table 2 
Comparison of the purity of different samples of 
DNase I
Sample % DNase I estimated by Specific 
activity 
Electro- Actin 
phoretic assay 
analysis 
DN-100 28.8 33.0 39.5 
DN-EP (1) 77.1 80.0 99.8 
DN-EP (2) 68.5 78.5 87.4 
G75 product 83.0 81.0 76.6 
MonoQ 
product 87.4 85.0 113.0 
The different assays are explained in section 2. The 
samples are DN-100 and two separate batches of DN-EP 
(‘electrophoretically pure’) from Sigma, and material 
purified from DN-100 by gel filtration on Sephadex G75 
Superfine and MonoQ 
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follow a similar pattern to the other two criteria, 
except that the activity of the G75 Superfine pro- 
duct is markedly lower than expected. By the argu- 
ment above, a possible explanation of the dis- 
crepancy suggests that a gradual loss of nuclease 
activity without concomitant loss of actin-binding 
capacity might have occurred during the prolonged 
storage of the G75 sample at -20°C. 
The data in fig.2 and table 2 show that DNase of 
a quality only slightly lower than that obtained 
from MonoQ can also be prepared from DN-100 
by conventional gel filtration chromatography on 
Sephadex G75 Superfine. However, separation on 
MonoQ has advantages in speed and capacity over 
Sephadex G75, and permits routine preparation of 
pure DNase on a scale impractical with conven- 
tional methods. The simplicity of the technique 
means that the amounts of DNase purified at one 
time can be better suited to specific needs, avoiding 
the possible problems inherent in long-term 
storage of the purified material. It seems 
reasonable to expect hat the method, perhaps with 
minor adaptations, will be applicable to purifica- 
tion of DNase from other commercial sources than 
Sigma DN-100, and perhaps also from pancreas 
itself. 
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